Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
eli lilly
ipo
4
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
amgen
armo biosciences
bristol-myers squibb
clinical trials
genentech
generic drugs
What
drugs
4
×
bio
roundup
pharmaceutical
advance
appetite
august
bails
biology
biotech
black
brand
bread
bridgebio
busy
butter
buyout
cancer
capital
car
cash
company
cytokine
days
decisions
develop
devices
diabetes
diamond’s
eli
emerges
enhanced
fda
files
firm
giant
grab
grabbed
hasn’t
headlines
Language
unset
Current search:
ipo
×
drugs
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
